Medican Enterprises, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDCN research report →
Companywww.medicaninc.com
Medican Enterprises, Inc. , a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada.
- CEO
- Kelvin Lindsey
- IPO
- 1995
- Employees
- 3
- HQ
- Las Vegas, NV, US
Price Chart
Valuation
- Market Cap
- $2.88M
- P/E
- -28.15
- P/S
- 3.08
- P/B
- 0.00
- EV/EBITDA
- -18.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- -101.25%
- Net Margin
- -16.93%
- ROE
- 0.00%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,210,000 · -279.18%
- EPS
- $0.00 · 0.00%
- Op Income
- $-2,000,000
- FCF YoY
- -13899.30%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -13.37
- Avg Volume
- 17.71K
Get TickerSpark's AI analysis on MDCN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Start Free Trial →Our MDCN Coverage
We haven't published any research on MDCN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MDCN Report →